Pharmaceutical Retailers

Tauriga Sciences (TAUG) Investors Find Metric +100% this Week

Tauriga Sciences (TAUG) Investors Find Metric +100% this Week

Steve Kanaval | |

A 500% move may signal to sell the news, save some powder to accumulate smaller Cannabis stocks. I like that when you buy shares at nine or ten cents, you know exactly how much you can lose.

Visualizing the Future of the Pharma Market

Visual Capitalist | |

With prescription drugs expected to be a $1.2 trillion industry by 2024, which are the most anticipated drugs and therapy areas in the pharma market?

Massive Short Squeeze in China SXT Pharma (SXTC) +75%

Steve Kanaval | |

Shorting Chinese stocks is a risky proposition in 2019, and lessons learned will come with some pain.

Interesting Investments: Drugs

Avery-Taylor Phillips | |

It's once again time to go into a gray area of investing. Can drugs like marijuana be profitable? What about lesser-known drugs? Investing directly or in related industries, there's money to be made.

​EyeGate's Potential is in Making a Trusted Substance Even Better

Stephen L Kanaval | |

Eyegate's OBG solution has a chance for commercialization in 2019

Johnson & Johnson Trial Kicks Off in NJ as Jury Deliberates California Case

Alex Hamilton | |

Johnson & Johnson continues to face significant exposure from personal injury lawsuits

​How Walgreens Survives and Thrives Against Amazon

MoneyShow | |

As a pharmacy retailer, Walgreens is very recession-resistant.

​Top Picks 2018: Why Cardinal Health Might be a Bargain

MoneyShow | |

Cardinal Health’s stock price has fallen noticeably over the past year for two reasons. The first is the potential entry of Amazon (AMZN) into the pharmaceutical distribution industry.

​Here's What the Bristol-Myers Squibb Means For Halozyme Therapeutics

Mark Collins | |

Bristol Myers-Squibb and Roche just validated Halozyme's proprietary technology in the same day. Here's what this means for the company.

Early Prescription Refills Allowed in Florida Ahead of Hurricane Irma

Edward Kim | |

Insurers are reminded to permit early refills before Irma hits (Image credit: Brashear's Pharmacy).

World Economic Forum at Davos 2019 - Ben Yablon Executive VP Salt Lending

Matt Bird sits down with Ben Yablon - Executive VP of Salt Lending - at the World Economic Forum in Davos January 2019